In December 2005, Eli Lilly and Firm agreed to plead responsible and spend $36 million in connection with the illegal marketing in the drug.[264] Income Reps had been experienced to promote Evista for breast most cancers and heart problems, to prompt or bait questions by Medical professionals, a